Literature DB >> 25416313

Intraoperative radiotherapy for gastrointestinal malignancies: contemporary outcomes with multimodality therapy.

Felipe A Calvo1, Claudio V Sole, Hugo Marsiglia, Eduardo Alvarado, Carlos Ferrer, Brian Czito.   

Abstract

The integration of intraoperative radiotherapy (IORT) into the multimodal treatment of gastrointestinal cancer is feasible and leads to high rates of local control. In-field tumoral control using IORT-containing strategies can be achieved in over 90 % of most cases, regardless of the site or status of the tumor (primary or recurrent). Electron beam IORT, or intraoperative electron radiation therapy, is the dominant technology used in institutions reporting data in publications the 21st century. Neither surgery nor systemic therapy is compromised by the integration of IORT-containing radiotherapy.

Entities:  

Mesh:

Year:  2015        PMID: 25416313     DOI: 10.1007/s11912-014-0419-8

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  35 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  Intraoperative radiotherapy for pancreatic cancer: 30-year experience in a single institution in Japan.

Authors:  Keiichi Jingu; Takaya Tanabe; Kenji Nemoto; Hisanori Ariga; Rei Umezawa; Yoshihiro Ogawa; Ken Takeda; Masashi Koto; Toshiyuki Sugawara; Masaki Kubozono; Eiji Shimizu; Keiko Abe; Shogo Yamada
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-22       Impact factor: 7.038

3.  Radiotherapy for pancreatic cancer: systematic nihilism or intraoperative realism.

Authors:  Felipe A Calvo; Vincenzo Valentini
Journal:  Radiother Oncol       Date:  2008-04-23       Impact factor: 6.280

4.  Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.

Authors:  J P Neoptolemos; J A Dunn; D D Stocken; J Almond; K Link; H Beger; C Bassi; M Falconi; P Pederzoli; C Dervenis; L Fernandez-Cruz; F Lacaine; A Pap; D Spooner; D J Kerr; H Friess; M W Büchler
Journal:  Lancet       Date:  2001-11-10       Impact factor: 79.321

5.  Multimodality therapy including salvage surgical resection and intraoperative radiotherapy for patients with squamous-cell carcinoma of the anus with residual or recurrent disease after primary chemoradiotherapy.

Authors:  Christopher L Hallemeier; Y Nancy You; David W Larson; Eric J Dozois; Heidi Nelson; Kristi A Klein; Robert C Miller; Michael G Haddock
Journal:  Dis Colon Rectum       Date:  2014-04       Impact factor: 4.585

Review 6.  Integration of radiation oncology with surgery as combined-modality treatment.

Authors:  Leonard L Gunderson; Jonathan B Ashman; Michael G Haddock; Ivy A Petersen; Adyr Moss; Jacques Heppell; Richard J Gray; Barbara A Pockaj; Heidi Nelson; Christopher Beauchamp
Journal:  Surg Oncol Clin N Am       Date:  2013-03-13       Impact factor: 3.495

7.  Intraoperative radiotherapy in the combination of adjuvant chemotherapy for the treatment of pT3N0M0 rectal cancer after radical surgery.

Authors:  Qing Zhang; Jeremy Tey; Zhe Yang; Ping Li; Lihua Peng; Ruiyao Jiang; Fei Xiong; Shen Fu; Jiade J Lu
Journal:  Am J Clin Oncol       Date:  2014-02       Impact factor: 2.339

8.  Chemoradiation for resected pancreatic adenocarcinoma with or without intraoperative radiation therapy boost: Long-term outcomes.

Authors:  Felipe A Calvo; Claudio V Sole; Freddy Atahualpa; Miguel A Lozano; Marina Gomez-Espi; Ana Calin; Pilar García-Alfonso; Luis Gonzalez-Bayon; Rafael Herranz; Jose Luis García-Sabrido
Journal:  Pancreatology       Date:  2013-09-30       Impact factor: 3.996

9.  Intra-operative radiotherapy (IORT) in pancreatic cancer: joint analysis of the ISIORT-Europe experience.

Authors:  Vincenzo Valentini; Felipe Calvo; Michele Reni; Robert Krempien; Felix Sedlmayer; Markus W Buchler; Valerio Di Carlo; Giovanni B Doglietto; Gerd Fastner; José L Garcia-Sabrido; GianCarlo Mattiucci; Alessio G Morganti; Paolo Passoni; Falk Roeder; Giuseppe R D'Agostino
Journal:  Radiother Oncol       Date:  2008-08-30       Impact factor: 6.280

10.  Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer.

Authors:  Raphaëla C Dresen; Marleen J Gosens; Hendrik Martijn; Grard A Nieuwenhuijzen; Geert-Jan Creemers; Alette W Daniels-Gooszen; Adriaan J van den Brule; Hetty A van den Berg; Harm J Rutten
Journal:  Ann Surg Oncol       Date:  2008-04-04       Impact factor: 5.344

View more
  1 in total

1.  Intraoperative radiotherapy for the treatment of thyroid cancer: a pilot study.

Authors:  Pei-Qiang Yi; Fang-Fang Nie; You-Ben Fan; Wei-Wei Yu; Chao-Su Hu; Xiao-Mao Guo; Jie Fu
Journal:  Oncotarget       Date:  2017-04-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.